Articles

Post Content

A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.

“The Fat One” gets its name from its status as one of the richest lotteries in the world.

John Buckingham of the Prudent Speculator takes a hard look at opportunities brought about by the stock market's focus on short-term developments

Don't leave money on the table because the rules have changed. Here's how to max out 2023 retirement contributions, and how to save even more in 2024

Orders for durable goods rose jumped 5.4% in November, the government said Friday. This is the largest gain since July 2020. It is the second gain in the past three months.

Karuna Therapeutics stock jumped 48% into record territory early Friday, after the biopharmaceutical company announced a $14 billion agreement to be bought by Bristol Myers Squibb.

Yields on U.S. Treasurys were flat to slightly lower Friday morning after data showed inflation continuing to slow in November, moving toward the Federal Reserve's target, in a trading session that will be shortened ahead of Christmas.

Americans are holding high levels of stocks. which may bode poorly for the next seven years, says a Wall Street veteran.

Should I be an S Corp or a C Corp? What’s QBI? When is my estimated payment due?

Oil futures rose Friday, on track for weekly gains as concerns over shipping disruptions via the Red Sea provided support.

Wedbush's Dan Ives is boosting his price target on Tesla's stock to $350, noting that he sees further gains in EV share.